Home
About
Company
Views and News
People
Contact us
Latest Views and News
30 January 2024
Abdul Latif Jameel Health announces a strategic acquisition of a majority sta...
Dubai, UAE; January 30, 2024: Abdul Latif Jameel Health, part of Abdul Latif Jameel, a nearly 80-...
Read More
01 March 2023
Genpharm and Apellis Pharmaceuticals Enter in an Exclusive Agreement
Dubai, March 1st 2023 Genpharm is pleased to announce it has entered into an exclusive agreement with Apellis ...
Read More
View All
About Us
What we do is simple – COMMIT . CONNECT . CURE
Our History
A glimpse into our history
Message From Our Founders
Our founders vision
Mantra and Values
We operate at the highest standard to serve and to support patients
Need to know more?
Contact Us
Therapeutic Areas
We cover different therapeutic areas in our portfolio
Our Capabilities and Expertise
Extensive experience within the MENAT Region
Our Partnerships
We join forces with organizations and individuals that share the same values
Board of Directors
Meet our board of directors
Leadership Team
Meet our team of experts
Our Departments
Our cross functional departments cater to every need
Home
About
About Us
Our History
Message From Our Founders
Mantra and Values
Company
Therapeutic Areas
Our Capabilities and Expertise
Our Partnerships
Views and News
Abdul Latif Jameel Health announces a strategic acquisition of a majority stake in Genpharm, a leading partner for rare disease market access in the Middle East
Genpharm and Apellis Pharmaceuticals Enter in an Exclusive Agreement
argenx and Genpharm Sign Exclusive Commercial and Distribution Agreement
Amicus Therapeutics and Genpharm Services Sign Distribution Agreement for the Treatment of Amenable Patients Living with Fabry Disease
View All
People
Board of Executive
Meet Our Leadership Team
Our Departments
Contact us
Page Not Found
The page you are looking for doesn't exist
or has been moved.
Go Home